Skip to content
Catalyst

curcuminFinding

Curcumin decreases LDL cholesterol

lowersModerate evidenceFindingreplicated ×1

01 · The sentence it was drawn from

“Furthermore, at the end of the study, the Curcumin group reported lower LDL levels ( P = 0.024) and higher HDL levels ( P = 0.024) versus the control group.”
Quoted verbatim from Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk.
This finding among the 119 findings on its endpoint

curcumin

LDL cholesterol

lowers

Who
Adults aged 50-74 y with type 2 diabetes and a 10-year ASCVD risk score >=5%, Cairo, Egypt; 85 randomised (42 curcumin, 43 control), 72 analysed (36 per group); open-label trial in which the control arm received conventional therapy only, with no placebo; the paper declares no primary endpoint and powered its sample size on change in HDL-C; LDL-C calculated by the Friedewald equation, HDL-C by enzymatic colorimetric assay
Dose studied
Oral Puritan's Pride Turmeric Curcumin 500 mg capsules (Curcuma longa root 450 mg plus turmeric extract 50 mg standardised to 95% curcuminoids), one capsule three times daily after meals (1500 mg/day) for 14 weeks, added to conventional therapy

Moderate evidencePMID 40759997 · 2025

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3R2J0DPFWQ7C1TW3X0X0M8Q